Bilateral progressive orbital myositis as immune-related adverse event of pembrolizumab. Nakajima I, Nakaizumi T, Tsuji H. Can J Ophthalmol 2024 Mar 8:S0008-4182(24)00040.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nakajima I, Nakaizumi T, Tsuji H. Bilateral progressive orbital myositis as immune-related adverse event of pembrolizumab. Can J Ophthalmol 2024 Mar 8:S0008-4182(24)00040.
PMID: 38462232